U.S. regulators on Monday approved a pill version of the blockbuster weight-loss drug Wegovy, marking the first time a daily oral medication has been green-lit to treat obesity.
The change is expected to drive even further adoption of the already widely popular GLP-1 class of drugs and help fight chronic obesity around the world.